CivicScience is a consumer analytics and advertising platform capturing over one million survey responses daily — turn real-time data into actionable insights here.
The choice to use a GLP-1 medication is not one made in a vacuum, nor are its impacts one-sided. In fact, this single decision has a powerful ripple effect. Beyond the intended weight loss goals, adults taking a GLP-1 medication demonstrate a variety of other unique consumer behaviors.
That’s why CivicScience has been tracking GLP-1 users to better understand purchasing trends across industries. In our latest report, the data cast a light on access and shortages, among other noteworthy behavior shifts.
Take our Poll: How favorable or unfavorable is your opinion of GLP-1 weight loss drugs?
However, with 38% of GLP-1 users indicating a decrease in dining out–double the percentage of those who indicated an increase (19%)–understanding which restaurants are still attracting those on weight loss medication is key to keeping these diners coming back for more.
A close look at a range of brands that CivicScience continuously studies, ranging from fast-food to upscale dining, uncovers which restaurants have the highest (and lowest) percentage of customers who take GLP-1 drugs.
These preferences indicate that while GLP-1 users are willing to splurge on a night out, they’re largely looking for dining options that reflect their changing dietary preferences and lifestyle choices, which include ordering smaller portion sizes or sharing food when they go out.
Given the percentage of Americans currently taking GLP-1 medications, their restaurant preferences can make a mark on the restaurant industry. Especially for companies seeking to appeal to those on weight loss medications, it’s important to keep in mind the power–and profit–that can come from giving your audience a seat at the table.
